Cyanine derivatives and related uses

US12516374B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12516374-B2
Application numberUS-202418424417-A
CountryUS
Kind codeB2
Filing dateJan 26, 2024
Priority dateDec 7, 2022
Publication dateJan 6, 2026
Grant dateJan 6, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides a compound of Formula (I), (II), or (III): an ionic derivative thereof, an isomer thereof, or a salt thereof. The present disclosure also provides conjugates of the compounds, and methods of using the compounds and the conjugates. The disclosure also provides the use of the compounds and conjugates in methods of sequencing nucleic acids.

First claim

Opening claim text (preview).

The invention claimed is: 1 . A compound, wherein the compound is or an ionic derivative thereof, or a salt thereof. 2 . A compound, wherein the compound is: or an ionic derivative thereof, or a salt thereof. 3 . A method of sequencing comprising: (a) contacting (i) a plurality of polymerases, (ii) a plurality of nucleic acid template molecules and (iii) a plurality of nucleic acid sequencing primers under conditions suitable to form a plurality of complexes comprising a polymerase bound to a nucleic acid duplex, wherein the nucleic acid duplex comprises a nucleic acid template molecule hybridized to a primer; (b) contacting the plurality of complexes with a plurality of nucleotides under conditions suitable for binding at least one nucleotide to one of the polymerases bound to a nucleic acid duplex; and (c) incorporating at least one nucleotide into the 3′ end of an extendible primer of at least one of the complexes, wherein at least one nucleotide in the plurality of nucleotides is labeled with the compound of claim 1 . 4 . A method of sequencing comprising: (a) contacting (i) a plurality of sequencing polymerases, (ii) a first plurality of nucleic acid template molecules and (iii) a plurality of nucleic acid sequencing primers under conditions suitable to form a plurality of complexes comprising a first polymerase bound to a nucleic acid duplex, wherein the nucleic acid duplex comprises a nucleic acid template molecule hybridized to a nucleic acid sequencing primer; (b) contacting the plurality of complexes with a plurality of multivalent molecules to form a plurality of complexes, each complex comprising one or more polymerases, nucleic acid templates and sequencing primers, wherein the nucleic acid templates and the sequencing primers are associated in a duplex, wherein individual multivalent molecules comprise a core attached to multiple nucleotide arms and each nucleotide arm is attached to a nucleotide unit; and wherein individual multivalent molecules in the plurality comprise the compound of claim 1 ; and (c) detecting the plurality of multivalent-complexed polymerases. 5 . A method of sequencing comprising: (a) contacting (i) a plurality of polymerases, (ii) a plurality of nucleic acid template molecules and (iii) a plurality of nucleic acid sequencing primers under conditions suitable to form a plurality of complexes comprising a polymerase bound to a nucleic acid duplex, wherein the nucleic acid duplex comprises a nucleic acid template molecule hybridized to a primer; (b) contacting the plurality of complexes with a plurality of nucleotides under conditions suitable for binding at least one nucleotide to one of the polymerases bound to a nucleic acid duplex; and (c) incorporating at least one nucleotide into the 3′ end of an extendible primer of at least one of the complexes, wherein at least one nucleotide in the plurality of nucleotides is labeled with the compound of claim 2 . 6 . A method of sequencing comprising: (a) contacting (i) a plurality of sequencing polymerases, (ii) a first plurality of nucleic acid template molecules and (iii) a plurality of nucleic acid sequencing primers under conditions suitable to form a plurality of complexes comprising a first polymerase bound to a nucleic acid duplex, wherein the nucleic acid duplex comprises a nucleic acid template molecule hybridized to a nucleic acid sequencing primer; (b) contacting the plurality of complexes with a plurality of multivalent molecules to form a plurality of complexes, each complex comprising one or more polymerases, nucleic acid templates and sequencing primers, wherein the nucleic acid templates and the sequencing primers are associated in a duplex, wherein individual multivalent molecules comprise a core attached to multiple nucleotide arms and each nucleotide arm is attached to a nucleotide unit; and wherein individual multivalent molecules in the plurality comprise the compound of claim 2 ; and (c) detecting the plurality of multivalent-complexed polymerases. 7 . A compound, wherein the compound is or an ionic derivative thereof, or a salt thereof. 8 . The compound of claim 7 , wherein the compound is: or an ionic derivative thereof, or a salt thereof. 9 . A method of sequencing comprising: (a) contacting (i) a plurality of polymerases, (ii) a plurality of nucleic acid template molecules and (iii) a plurality of nucleic acid sequencing primers under conditions suitable to form a plurality of complexes comprising a polymerase bound to a nucleic acid duplex, wherein the nucleic acid duplex comprises a nucleic acid template molecule hybridized to a primer; (b) contacting the plurality of complex

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12516374B2 cover?
The present disclosure provides a compound of Formula (I), (II), or (III): an ionic derivative thereof, an isomer thereof, or a salt thereof. The present disclosure also provides conjugates of the compounds, and methods of using the compounds and the conjugates. The disclosure also provides the use of the compounds and conjugates in methods of sequencing nucleic acids.
Who is the assignee on this patent?
Element Biosciences Inc
What technology area does this patent fall under?
Primary CPC classification C09B23/086. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).